Literature DB >> 19390853

Clinical features and molecular analysis in Thai patients with HbH disease.

Vichai Laosombat1, Vip Viprakasit, Thirachit Chotsampancharoen, Malai Wongchanchailert, Sudarat Khodchawan, Worawut Chinchang, Benjamas Sattayasevana.   

Abstract

We studied the alpha-globin gene abnormalities, the clinical features, hematologic values, growth assessment, transfusion therapy, and serum ferritin levels of patients with hemoglobin H (HbH) disease in southern Thailand. HbH disease in 83 of the 147 patients was the deletional type of HbH. The remaining 64 patients was the nondeletional type of HbH disease. All 83 patients with the deletional type were double heterozygotes of alpha(0)-thalassemia and alpha(+)-thalassemia. The Southeast Asian type of alpha(0)-thalassemia accounted for 98% of the Thai patients with HbH disease and the Thai type of alpha(0)-thalassemia made up the rest. A 3.7-kb deletion accounted for 91% of alpha(+)-thalassemia, and a 4.2-kb deletion made up the rest of the deletional type. In patients with nondeletional type of HbH disease, the Constant Spring variant was the majority of the disease. Newborns with a nondeletional genotype had higher mean corpuscular volume, had higher mean corpuscular hemoglobin, had higher red blood cell distribution width, had lower mean corpuscular hemoglobin concentration, and had higher proportions of Hb Bart's than those with a deletional genotype. Twenty-one percent of children with HbH disease had growth deficiency. A genotype-phenotype correlation was found; patients with the nondeletional type of HbH disease had more symptoms at a younger age, more severe hemolytic anemia, more growth deficiency, more dysmorphic facial features, larger spleens, larger livers, and higher serum ferritin levels and required more transfusions than patients with deletional HbH disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19390853     DOI: 10.1007/s00277-009-0743-5

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  20 in total

1.  Molecular characterization of Hb H disease in southern Thailand.

Authors:  Kesara Nittayaboon; Chamnong Nopparatana
Journal:  Int J Hematol       Date:  2018-07-13       Impact factor: 2.490

Review 2.  Alpha-thalassaemia.

Authors:  Cornelis L Harteveld; Douglas R Higgs
Journal:  Orphanet J Rare Dis       Date:  2010-05-28       Impact factor: 4.123

3.  Iranian patients with hemoglobin H disease: genotype-phenotype correlation.

Authors:  Mostafa Paridar; Ebrahim Azizi; Bijan Keikhaei; Vahideh Takhviji; Iman Baluchi; Abbas Khosravi
Journal:  Mol Biol Rep       Date:  2019-07-04       Impact factor: 2.316

4.  Acute Non-Atherosclerotic ST-Segment Elevation Myocardial Infarction in an Adolescent with Concurrent Hemoglobin H-Constant Spring Disease and Polycythemia Vera.

Authors:  Ekarat Rattarittamrong; Lalita Norasetthada; Adisak Tantiworawit; Chatree Chai-Adisaksopha; Sasinee Hantrakool; Thanawat Rattanathammethee; Pimlak Charoenkwan
Journal:  Hematol Rep       Date:  2015-09-23

5.  Comparative plasma protein profiling of hemoglobin H disease.

Authors:  Kamonlak Leecharoenkiat; Wannapa Sornjai; Kornpat Khungwanmaythawee; Atchara Paemanee; Chartchai Chaichana; Sittiruk Roytrakul; Suthat Fucharoen; Saovaros Svasti; Duncan R Smith
Journal:  Dis Markers       Date:  2014-06-15       Impact factor: 3.434

Review 6.  Identification and key management of non-transfusion-dependent thalassaemia patients: not a rare but potentially under-recognised condition.

Authors:  Vip Viprakasit; Paul Tyan; Sarayuth Rodmai; Ali T Taher
Journal:  Orphanet J Rare Dis       Date:  2014-09-30       Impact factor: 4.123

7.  DNA studies are necessary for accurate patient diagnosis in compound heterozygosity for Hb Adana (HBA2:c.179>A) with deletional or nondeletional α-thalassaemia.

Authors:  Jin Ai Mary Anne Tan; Siew Leng Kho; Chin Fang Ngim; Kek Heng Chua; Ai Sim Goh; Seoh Leng Yeoh; Elizabeth George
Journal:  Sci Rep       Date:  2016-06-08       Impact factor: 4.379

Review 8.  Treating iron overload in patients with non-transfusion-dependent thalassemia.

Authors:  Ali T Taher; Vip Viprakasit; Khaled M Musallam; M Domenica Cappellini
Journal:  Am J Hematol       Date:  2013-03-08       Impact factor: 10.047

9.  Clinical features and molecular analysis of Hb H disease in Taiwan.

Authors:  Yu-Hua Chao; Kang-Hsi Wu; Han-Ping Wu; Su-Ching Liu; Ching-Tien Peng; Maw-Sheng Lee
Journal:  Biomed Res Int       Date:  2014-08-28       Impact factor: 3.411

Review 10.  When to consider transfusion therapy for patients with non-transfusion-dependent thalassaemia.

Authors:  A T Taher; A Radwan; V Viprakasit
Journal:  Vox Sang       Date:  2014-10-07       Impact factor: 2.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.